• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新生儿筛查的公共问责制:集体认知与决策。

Public accountability of newborn screening: collective knowing and deciding.

机构信息

Inter-University Research Centre for Technology, Work and Culture, Modern Biotechnology, Schloegelgasse 2, 8010 Graz, Austria.

出版信息

Soc Sci Med. 2010 Mar;70(6):926-33. doi: 10.1016/j.socscimed.2009.12.001. Epub 2010 Jan 12.

DOI:10.1016/j.socscimed.2009.12.001
PMID:20061074
Abstract

A number of European countries have expanded their screening programme considerably during the last decade. Other countries have, however, not expanded their programme substantially. In this paper, I will compare UK and Austria, two countries representing two ends of the European spectrum. Focussing on the decision-making processes behind the design and expansion of newborn screening, I draw on Sheila Jasanoff's concept of "civic epistemology" (Jasanoff, S. (2005). Designs on Nature. Princeton and Oxford: Princeton University Press.) to investigate how the chosen countries provide information in order to give account for their respective screening policies. In particular, I analyse how key institutions in the UK and Austria use scientific expertise to explain and justify national screening programmes. For this purpose, I compare the material that is made available to the public, including policy documents, scientific studies, medical guidelines, legal regulation, advisory committee reports and public engagement exercises. It was found that the observed differences in the accountability practices are rooted in nationally traditional forms of policy making. However, whether or not these repertoires become indeed realised is a more contingent matter and is often triggered by events which evoke a response from the medical and policy-making actors.

摘要

在过去十年中,许多欧洲国家大幅扩大了他们的筛查计划。然而,其他国家并没有大幅扩大他们的计划。在本文中,我将比较英国和奥地利这两个代表欧洲两个极端的国家。我将重点关注新生儿筛查设计和扩展背后的决策过程,借鉴希拉·贾萨诺夫的“公民认识论”概念(Jasanoff,S.(2005)。自然设计。普林斯顿和牛津:普林斯顿大学出版社。),以调查所选择的国家如何提供信息以说明其各自的筛查政策。特别是,我分析了英国和奥地利的关键机构如何利用科学专业知识来解释和证明国家筛查计划的合理性。为此,我比较了向公众提供的材料,包括政策文件、科学研究、医疗指南、法律规定、咨询委员会报告和公众参与活动。结果发现,所观察到的问责实践差异源于国家传统的决策形式。然而,这些方案是否真正实现是一个更偶然的问题,通常是由引发医疗和政策制定者做出反应的事件引发的。

相似文献

1
Public accountability of newborn screening: collective knowing and deciding.新生儿筛查的公共问责制:集体认知与决策。
Soc Sci Med. 2010 Mar;70(6):926-33. doi: 10.1016/j.socscimed.2009.12.001. Epub 2010 Jan 12.
2
Methods of legitimation: how ethics committees decide which reasons count in public policy decision-making.合法化方法:伦理委员会如何决定公共政策决策中的哪些理由有效。
Soc Sci Med. 2014 Jul;113:34-41. doi: 10.1016/j.socscimed.2014.04.043. Epub 2014 May 2.
3
Ethical, legal and social issues in newborn screening in the United States.美国新生儿筛查中的伦理、法律和社会问题。
Southeast Asian J Trop Med Public Health. 2003;34 Suppl 3:52-8.
4
Citizen participation in health decision-making: past experience and future prospects.公民参与健康决策:过去的经验与未来的前景
J Public Health Policy. 2002;23(1):12-32.
5
Newborn blood spot screening in four countries: stakeholder involvement.四个国家的新生儿血斑筛查:利益相关者的参与
J Public Health Policy. 2008 Apr;29(1):121-42. doi: 10.1057/palgrave.jphp.3200161.
6
The complex promise of newborn screening.新生儿筛查的复杂前景。
Indian J Med Ethics. 2009 Jul-Sep;6(3):142-8. doi: 10.20529/IJME.2009.046.
7
Balancing benefits and risks for cystic fibrosis newborn screening: implications for policy decisions.平衡囊性纤维化新生儿筛查的益处与风险:对政策决策的影响
J Pediatr. 2005 Sep;147(3 Suppl):S109-13. doi: 10.1016/j.jpeds.2005.08.019.
8
Policy issues related to expanded newborn screening: a review of three genetic/metabolic disorders.与扩大新生儿筛查相关的政策问题:对三种遗传/代谢性疾病的综述
Policy Polit Nurs Pract. 2007 Aug;8(3):201-9. doi: 10.1177/1527154407303498.
9
Newborn blood spot screening.新生儿血斑筛查
RCM Midwives. 2005 May;8(5):216-8.
10
[Half a century of newborn screening in Spain: Evolution of ethical, legal and social issues (ELSIs). Part III, social issues.].西班牙新生儿筛查的半个世纪:伦理、法律和社会问题(ELSI)的演变。第三部分,社会问题。
Rev Esp Salud Publica. 2021 Jan 26;95:e202101016.

引用本文的文献

1
Coming to terms with the imperfectly normal child: attitudes of Israeli parents of screen-positive infants regarding subsequent prenatal diagnosis.接纳不那么正常的孩子:以色列筛查呈阳性婴儿的父母对后续产前诊断的态度。
J Community Genet. 2019 Jan;10(1):41-50. doi: 10.1007/s12687-018-0361-9. Epub 2018 Mar 5.
2
Review of Current International Decision-Making Processes for Newborn Screening: Lessons for Australia.现行国际新生儿筛查决策过程综述:对澳大利亚的启示。
Front Public Health. 2015 Sep 10;3:214. doi: 10.3389/fpubh.2015.00214. eCollection 2015.
3
Funding decisions for newborn screening: a comparative review of 22 decision processes in Europe.
新生儿筛查的资金决策:对欧洲 22 个决策过程的比较评估。
Int J Environ Res Public Health. 2014 May 19;11(5):5403-30. doi: 10.3390/ijerph110505403.
4
The development and organization of newborn screening programs in Turkey.土耳其新生儿筛查项目的发展与组织。
J Clin Lab Anal. 2014 Jan;28(1):63-9. doi: 10.1002/jcla.21645. Epub 2013 Dec 27.